Asthma Inhaler: New Combination Inhaler in Patients With Asthma: "The purpose of this study is to evaluate the long-term safety of the fixed combination asthma drug FlutiForm HFA MDI (containing fluticasone propionate and formoterol fumarate) in adult and adolescent patients with mild to moderate-severe asthma."
Saturday, November 11, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment